Seronegative Rubella IgG Status in Pregnant Women Visiting Tertiary Care Hospital

Authors

  • Atifa Afsheen Sharique
  • Muhammad Sharique
  • Asha Mahesh
  • Syed Wajahat Shah

Keywords:

Congenital rubella syndrome, Immunization, Seronegativity, Pregnancy

Abstract

Objective: To determine the seronegative rubella IgG status in pregnant women visiting antenatal clinic at Jinnah Medical College Hospital.

Materials and Methods: This cross sectional study was carried out after ethical approval in Jinnah Medical College Hospital, Karachi from 1st April 2014 to 31st March 2015.Ninety three primigravidae in first trimester presenting to antenatal clinic were selected from the obstetrics and gynecology OPD. Blood samples of all women were taken and sent to laboratory for evaluation of IgG rubella antibody by ELISA technique. SPSS version 20 was used for data analysis.

Results:Out of 93 pregnant women, 11(11.8%) were negative for rubella IgG antibody in the first trimester of pregnancy. Mean ±SD of age of the study participants was 25.66(± 6.29) years. Majority of the women patients belonged to low socioeconomic group having educational status less than matriculation.

Conclusion: Rubella seronegativity is common in pregnant women visiting tertiary care hospital

References

Rasmussen SA, Human teratogens update 2011: Can we ensure safety during pregnancy? Birth Defects Res A ClinMolTeratol 2012;94(3):123-8

Adam MP, Polifka JE, Friedman JM. Evolving knowle-dge of the teratogenicity of medications in human preg-nancy. Am J Med Genet C Semin Med Genet.2011;157: 175-82

WHO. Rubella vaccines. Position paper WklyEpidemiol Rec 2011;86(29): 301-16

Honarvar B, Moghadami M, Moattari A, Emami A, Od-oomi N. Seroprevalence of Anti-Rubella and Anti-Mea-sles IgG Antibodies in pregnant women in Shiraz, Sout-hern Iran: Outcomes of a Nationwide Measles-Rubella Mass Vaccination Compaign. PLOS ONE 2013; 8(1): e55043. Doi: 10.1371/ journal. Pone.0055043

Cutts FT, Robertson SE, Diaz-Ortega JL, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. Bull World Health Organ 1997; 75:55-68

Aksakal FN, Maral I, Cirak MY, Aygun R. Rubella sero-prevalence among women of childbearing age residing in a rural region: is there a need for rubella vaccination in Turkey? Jpn J Infect Dis 2007; 60:157-60

Cutts FT, Vynnycky E. Modeling the incidence of con-genital rubella syndrome in developing countries. Int J Epidemiol. 1999; 28:1176-84

Condon RJ, Bower C. Rubella vaccination and congenital rubella syndrome in Western Australia.Med J Aust. 1993; 158:379-82

Lee JY, Bowden DS. Rubella virus replication and links to teratogenicity. ClinMicrobiol Rev 2000; 13:571-87

Obican S, Scialli AR. Teratogenic exposures. Am J Med Genet C Semin Med Genet. 2012;157:150-69

Center for Disease Control and Prevention (CDC). Rev-ised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR Morb Mortal Wkly Rep 2001; 50:111-7

Iqbal A, Bokhari SR. Status of Rubella IgG antibody in general population at Lahore. Pak J Pathol 1997; 8:37-41

Vargas-Leguás H, CampinsMartí M, Juste Sánchez C, Martínez Gómez X, Hermosilla Pérez E, CaberoRoura L. Rubella susceptibility of immigrant pregnant women in Catalonia. Med Clin (Barc). 2009; 132:344-7

Miller CL. Rubella in the developing world. Epidemiol Infect. 1991; 107:63-8

Sharma HJ, Padbidri VS, Kapre SV, Jadhav SS, Dhere RM, Parekh SS, et al. Seroprevalence of rubella and immunogenicity following rubella vaccination in adole-scent girls in India. J Infect DevCtries. 2011; 5:74-81

Hamdan HZ, Abdelbagi IE, Nasser NM, Adam I. Serop-revalence of cytomegalovirus and rubella among pregnant women in western Sudan. Virol J 2011; 8: 217

Onakewhor JU, Chiwuzie J. Seroprevalence survey of rubella infection in pregnancy at the University of Benin Teaching Hospital, Benin City, Nigeria. Niger J ClinPract 2011. 14(2): 140-5

Mora-Garci´a GJ, Ramos-Clason E, Mazenett E, Go´mez-Camargo D. The seroprevalence of IgG antibodies against rubella (German measles) in 10– 49 year-old women from Cartagena, Colombia 2011; Rev SaludPublica (Bogota).13(2): 288–97

McElroy R, Laskin M, Jiang D, Shah R, Ray JG. Rates of rubella immunity among immigrant and non-immig-rant pregnant women. J ObstetGynaecol Can 2009; 31(5):409-13

Adil MM, Zubair M, Alam AY, Raja KS. Identification of seronegative pregnant women eligible for immuniza-tion against Rubella. Rawal Med J 2005; 30:22-4

Iqbal A, Bokhari SR. Occurance of Rubella antibody IgG in General Population. Mother & Child. 1997; 35:17-22

Kharal SA, Khan MA. Prevalence of Rubella Seropos-itivity at successive stages of Pregnancy. Pak Armed Forces Med J 1997; 47:11-4

Kharal SA, Khan MA. Rubella antibodies in Women with Full-Term Normal Delivery and in their Neonates. Pak J ObstetGynaecol 1996; 9:29-31

Babigumira JB, Morgan I, Levin A: Health economics of rubella: a systematic review to assess the value of rubella vaccination. BMC Public Health 2013; 13:406-17

Robertson SE, Featherstone DA, Gacic-Dobo M, Hersh BS. Rubella and congenital rubella syndrome: global update. Rev Panam Salud Publica 2003; 14:306-15

Downloads

Published

2015-12-03

How to Cite

Sharique, A. A. ., Sharique, M. ., Mahesh, A. ., & Shah, S. W. . (2015). Seronegative Rubella IgG Status in Pregnant Women Visiting Tertiary Care Hospital. Journal of Bahria University Medical and Dental College, 5(4), 167–170. Retrieved from https://jbumdc.bahria.edu.pk/index.php/ojs/article/view/603

Issue

Section

Original Articles